SAFElife™ Benzodiazepines (BZO) Liquid & Powder Drug Test
SAFElife™ Benzodiazepines (BZO) Liquid & Powder Drug Test
The SAFElife™ Benzodiazepines (BZO) Liquid & Powder Drug Test is a rapid, easy-to-use testing solution designed for the qualitative detection of benzodiazepines in liquid and powder samples. This targeted detection test enables quick identification of benzodiazepine presence, supporting timely safety decisions and effective substance screening. Engineered for accuracy and convenience, SAFElife™ delivers reliable results in both field and professional testing environments.
Key Features
- Targeted detection: Specifically identifies benzodiazepines (BZO) in liquid and powder samples
- Rapid results: Provides clear and reliable results within minutes
- High accuracy: Designed for consistent and dependable performance
- User-friendly design: Simple procedure suitable for quick and on-site testing
- Efficient screening: Enables fast detection of substances for improved safety and monitoring
Applications in MAT Clinics
- Harm Reduction Programs: Supports screening of substances for benzodiazepine presence
- Public Health Initiatives: Assists in monitoring substance use trends
- Law Enforcement: Useful for rapid on-site substance identification
- Laboratory Screening: Suitable for preliminary analysis prior to confirmatory testing
Compliance & Safety
The SAFElife™ Benzodiazepines (BZO) Liquid & Powder Drug Test is manufactured in ISO-certified facilities under strict quality control standards. It complies with applicable regulatory and safety guidelines, ensuring reliable performance and consistency for professional and field use.
Validate your login